The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
Help: Registration number
ACTRN12626001234303
Ethics application status
Help: Ethics application status
Approved
Date submitted
Help: Date submitted
7/09/2026
Date registered
Help: Date registered
12/10/2026
Date last updated
Help: Date last updated
12/10/2026
Date data sharing statement initially provided
Help: Data sharing statement date
12/10/2026
Type of registration
Help: Type of registration
Prospectively registered

Titles & IDs
Public title
SMS-Text messaging for heat adaptation behaviours for Australians with chronic health conditions
Scientific title
A randomised controlled trial of a tailored text message intervention for heat adaptation in adult Australians: Heat Outcome Trial (HOT) TEXT
Additional trial identifiers [1] 318195 0
Nil
Universal Trial Number (UTN)
Trial acronym
Related trial records

Health condition
Health condition(s) studied:
cardiovascular disease 343257 0
respiratory disease 343258 0
renal disease 343259 0
metabolic disease 343436 0
Condition category
Condition code
Cardiovascular 339369 339369 0 0
Coronary heart disease
Cardiovascular 339370 339370 0 0
Hypertension
Metabolic and Endocrine 339525 339525 0 0
Diabetes
Renal and Urogenital 339526 339526 0 0
Kidney disease
Respiratory 339527 339527 0 0
Asthma
Respiratory 339528 339528 0 0
Chronic obstructive pulmonary disease
Public Health 339529 339529 0 0
Health promotion/education
Public Health 339530 339530 0 0
Health service research

Intervention/exposure
Study type
Interventional
Description of the intervention or exposure
Intervention Background: Currently, generic heat warnings are the standard of care in public health notifications. However, such communication may lack efficiency, fail to reach the target population, or may lead to suboptimal behaviour change if it isn't timely, accessible, consistent or considered trustworthy. We completed an earlier proof-of-concept (pilot study) of a text messaging intervention, to assess tailored SMS warnings for acceptability and feasibility. Participants indicated that targeted messaging via SMS was both feasible and acceptable and engagement with message guidance was strong amongst all participants in the intervention arm. The current study is a large-scale randomised controlled trial (RCT) using an SMS-based messaging intervention providing disease-specific messages to adults with chronic conditions (such as cardiovascular disease, respiratory disease, kidney disease).

Who: The research team, comprising investigators with expertise spanning information technology, climate and health, clinical care, consumer engagement, and research design, will deliver the intervention. Clinicians will inform the tailored text message content.

Delivery: Trial participants will be randomly assigned to one of two arms:
Control arm - this group will be receiving general information via text message (SMS) on managing heat;
Intervention arm - this group will be receiving tailored, disease- and location-specific advice messages via text (Short Message Service -SMS). Message length is estimated to be approximately 150 words or less, and and will be one-way interactions i.e., participants will not be required to provide a response. The intervention will be triggered by a rule-based algorithm using both Bureau of Meteorology (BOM) heat alert data, and participant (demographic, vulnerabilities, health status) data. Messages will be selected and tailored according to a message library developed by the research team (and informed by expert clinicians). Messages will be text-based and contain menu response options for accessing additional information e.g., health management actions. An example of tailoring may be: "Hi [Name], This is an extreme heat warning in [Location] from [Date] to [Date]. You are at higher risk [moderate to very high risk]of heat illness due to [health condition, medication X etc.]. [Action 1] is advised by [Time e.g., 9am], [Action 2e.g.. drink more water than usual even if you're not feeling thirsty]. [Action 3]. For more information[Response menu options]. Call 000 if you experience [Symptoms]."

Mode of delivery: Survey data will be collected via the REDCap platform. Our experienced software development team will employ commercial off-the-shelf (COTS) technology platforms which will integrate participant data and weather data (from the Bureau of Meteorology) including heatwave warning data, to tailor messages. The virtual intervention will issue text messages facilitated though Amazon Web Services. MS Teams teleconferencing platform will be used for the Focus Group interviews.

Frequency of intervention: text message intervention will be delivered up to two days prior (or upon availability of the forecast) to forecasted heat event, followed by a text message one day prior to the event.

Intervention location: This study will be conducted online at participants’ preferred location (e.g., place of residence) across Australia (including all states and territories).

Monitoring: We will be conducting post-intervention surveys at 3-days and 7-days post-trial.
Intervention code [1] 335099 0
Prevention
Intervention code [2] 335100 0
Lifestyle
Intervention code [3] 335101 0
Behaviour
Description of the comparator or control
Participants will receive general information on managing heat prior to an extreme heat event via SMS. Message length is estimated to be approximately 100 words or less. Message content will contain weather data about an upcoming heatwave event and general health advice about staying cool during extreme temperatures.
Control group
Active

Outcomes
Primary outcome [1] 346715 0
Changes in heat-related symptoms
Timepoint [1] 346715 0
Baseline (at enrolment, pre-heatwave and before text-messaging); 3 days post-heatwave event
Secondary outcome [1] 467489 0
Changes in heat-adaptive behaviours
Timepoint [1] 467489 0
3-days post-heatwave event
Secondary outcome [2] 467490 0
Changes in acute care utilisation
Timepoint [2] 467490 0
Baseline (at enrolment, prior to the heatwave period); 3-day post heatwave event
Secondary outcome [3] 467491 0
Messaging intervention usability
Timepoint [3] 467491 0
4-days and 7-days post-intervention

Eligibility
Key inclusion criteria
Adults 18 years+ residing in Australia
Participants with chronic conditions (for example, cardiovascular, respiratory or kidney diseases) will be recruited. Participants will meet the following eligibility criteria:
Adults aged 18 years and older residing in Australia
Any sex, ethnicity and medical background
Possess a mobile phone and an Australian number
Able to read and communicate in English
Willingness to provide informed consent and to participate and comply with study requirements
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Healthy volunteers
No
Key exclusion criteria
Individuals younger than 18 yrs (children)
Individuals not residing in Australia
Residing in nursing home or aged care facilities
Participation in another risk communication trial for heat adaptation at time of study

Study design
Purpose of the study
Prevention
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Central randomisation will be performed by an independent team member (statistician) to maintain allocation concealment until enrolment. The trial will be double-blind (participants and researchers).
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Simple randomisation: Computer-based random number generation
Masking / blinding
Blinded (masking used)
Who is / are masked / blinded?
The people receiving the treatment/s


The people analysing the results/data
Intervention assignment
Parallel
Other design features
Phase
Not Applicable
Type of endpoint/s
Efficacy
Statistical methods / analysis
5566 adult Australians. We calculate sample size based on the primary outcome of self-reported heat symptoms. According to a sample of 499 older Australians, up to 20% reported experiencing some heat symptoms [1]. Several meta-analyses show that tailored text message interventions can have large to moderate effect sizes from 54% to 32% [2, 3] in improving outcomes such as smoking cessation, physical activity, and medication adherence. To remain conservative, we propose the trial would result in a relatively small effect size of 25% (Relative Risk of 1.25), which means that 15% of participants in the intervention group will experience self-diagnosed heat symptoms, compared to 20% in the control group. A total sample of 5566 participants is required to detect this difference, with 80% power and a two-sided significance level of 0.05 [4]. This calculation has also factored in a study dropout rate of 25% and a further 60% possibility of participants not being exposed to heatwaves (based on a heuristic assessment of historic patterns).

References:
[1] Nitschke M, Hansen A, Bi P, Pisaniello D, Newbury J, Kitson A, et al. Risk Factors, Health Effects and Behaviour in Older People during Extreme Heat: A Survey in South Australia. International Journal of Environmental Research and Public Health [Internet]. 2013; 10(12):[6721-33 pp.]
[2] Head KJ, et al. Efficacy of text messaging-based interventions. Soc Sci Med. 2013;97:41-8.
[3] Sahin C, et al. Tailored mobile text messaging interventions. Digit Health. 2019;5.
[4] Noordzij M, et al. Sample size calculations. Nephrol Dial Transplant. 2010;25(5):1388-93.

Recruitment
Recruitment status
Not yet recruiting
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
ACT,NSW,NT,QLD,SA,TAS,WA,VIC

Funding & Sponsors
Funding source category [1] 322762 0
University
Name [1] 322762 0
Macquarie University
Country [1] 322762 0
Australia
Primary sponsor type
University
Name
Macquarie University
Address
Country
Australia
Secondary sponsor category [1] 325683 0
None
Name [1] 325683 0
Address [1] 325683 0
Country [1] 325683 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 321198 0
Macquarie University Human Research Ethics Committee Medical Sciences
Ethics committee address [1] 321198 0
Ethics committee country [1] 321198 0
Australia
Date submitted for ethics approval [1] 321198 0
20/02/2025
Approval date [1] 321198 0
14/04/2025
Ethics approval number [1] 321198 0

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 152990 0
Prof Enrico Coiera
Address 152990 0
Level 6, 75 Talavera Rd, Macquarie University, 2109, NSW
Country 152990 0
Australia
Phone 152990 0
+61 2 9850 2403
Fax 152990 0
Email 152990 0
Contact person for public queries
Name 152991 0
Dr Hania Rahimi Ardabili
Address 152991 0
Level 6, 75 Talavera Rd, Macquarie University, 2109, NSW
Country 152991 0
Australia
Phone 152991 0
+61 2 9850 9419
Fax 152991 0
Email 152991 0
Contact person for scientific queries
Name 152992 0
Enrico Coiera
Address 152992 0
Level 6, 75 Talavera Rd, Macquarie University, 2109, NSW
Country 152992 0
Australia
Phone 152992 0
+61 2 9850 2403
Fax 152992 0
Email 152992 0

Data sharing statement
Will the study consider sharing individual participant data?
Yes
Will there be any conditions when requesting access to individual participant data?
Persons/groups eligible to request access:
• Researchers
Conditions for requesting access:
• Yes, conditions apply:
• Requires review on a case-by-case basis by the trial custodian, sponsor or data sharing committee
• Requires a scientifically sound proposal or protocol
• Requires approval by an ethics committee
• Requires a data sharing agreement between data requester and trial custodian or sponsor
What individual participant data might be shared?
• De-identified individual participant data:
• All outcomes data
• Published results
• Primary outcome(s)
What types of analyses could be done with individual participant data?
• Systematic reviews and meta-analyses
• Studies exploring new research questions
When can requests for individual participant data be made (start and end dates)?
From:
After publication of main results
To:
A finite period of: 15 years
Where can requests to access individual participant data be made, or data be obtained directly?
• Email of trial custodian, sponsor or committee: [email protected]

Are there extra considerations when requesting access to individual participant data?
No


What supporting documents are/will be available?

TypeCitationLinkEmailOther DetailsAttachment
Ethical approval    Approval Letter_15_04_2025.pdf


Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.